Profit after tax (PAT) jumped 201.6% YoY to Rs 96.5 crore, underscoring a significant improvement in bottom-line performance. The company’s total income for Q2FY26 stood at Rs 516.1 crore, marking a 63.7% year-on-year (YoY) growth. EBITDA surged 138.8% YoY to Rs 156.9 crore, while the EBITDA margin expanded by 960 basis points to 30.4%, reflecting strong operational leverage.
On the balance sheet front, the company maintained a net debt-free position, with net debt at Rs (-6.6) crore as of the end of Q2FY26 — compared with Rs (-94.3) crore in Q2FY25 and Rs (-164.7) crore in Q1FY26.
For the first half of FY26, Neuland Labs reported total income of Rs 816.7 crore, up 7.5% YoY. EBITDA came in at Rs 199.1 crore, a modest 2.5% YoY increase, while the EBITDA margin stood at 24.4%, lower by 120 bps YoY.
However, PAT for the half year declined 15.4% YoY to Rs 110.2 crore. The company continued to remain net debt-free, with net debt at Rs (-6.6) crore as of H1FY26 end, compared with Rs (-94.3) crore in H1FY25.
The company’s earnings per share rose to Rs 72.5, up from Rs 24.9 per share, Neuland’s investor presentation showed.“The record high revenue this quarter driven by CMS commercial projects led to the operating leverage reflected in the EBITDA margins, and we expect this momentum to continue through the rest of the year. Given the investments we are making Neuland is well positioned to take advantage of the number of growth opportunities available to us in both the CDMO as well as the generic APIs space,” the management said.At about 9:20 am, the company’s shares were trading at Rs 19,440, up 9% from the last close on the NSE. Neuland Labs’ share price has been in top form, rising 55% in the last 6 months. The stock is up nearly 1,800% in the last 5 years.
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)